Articles

Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib

Centre of Cancer Biomarkers CCBIO, Department of Clinical Science, Precision Oncology Research Group, University of Bergen, Norway
Centre of Cancer Biomarkers CCBIO, Department of Clinical Science, Precision Oncology Research Group, University of Bergen, Norway
Department of Clinical Medicine, University of Bergen, Norway;Neuroimmunology Lab, Haukeland University Hospital, Bergen, Norway
Mass Cytometry Facility, University of Zurich, Switzerland
Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
Flow Cytometry Facility, University of Zurich, Switzerland
Hematology Department, Cliniques Universitaires St Luc, Brussels, Belgium
Department of Medicine, Oslo University Hospital, Norway
Department of Hematology, Medical University of Gdańsk, Poland
Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands
Department of Hematology, University Hospital Center Rebro, Zagreb, Croatia
Internal Medicine, Hospital Feldkirch, Austria
Department of Hemato-Oncology, Stavanger University Hospital, Norway
Clinic for Hematology, University Hospital Sofia, Bulgaria
Hematology Unit, Aarhus University Hospital, Denmark
Department of Medicine, Karolinska University Hospital, Stockholm, Sweden
Department of Internal Medicine IV, Wels-Grieskirchen Hospital, Wels, Austria
Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands
Department of Hematology, University Hospital Leuven, Belgium
4th Department of Internal Medicine – Hematology, University Hospital Hradec Kralove, Czech Republic
Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands
Department of Hematology and Medical Oncology, Universitätsklinikum Jena, Germany
Department of Hematology, St Olavs Hospital, Trondheim, Norway;IKM, NTNU, Trondheim, Norway
Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Department of Hematology, Finland;Department of Clinical Chemistry, University of Helsinki, Finland
Department of Hematology and Oncology, Innsbruck Medical University and Tyrolean Cancer Research Institute, Innsbruck, Austria
NMDTI, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA
Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Department of Hematology, Finland
Department of Hematology and Oncology, Innsbruck Medical University and Tyrolean Cancer Research Institute, Innsbruck, Austria;Medical Clinic 3, Oncology, Hematology and Rheumatology, University Hospital Bonn (UKB), Germany
Centre of Cancer Biomarkers CCBIO, Department of Clinical Science, Precision Oncology Research Group, University of Bergen, Norway;Department of Internal Medicine, Haukeland University Hospital, Bergen, Norway
Vol. 102 No. 8 (2017): August, 2017 https://doi.org/10.3324/haematol.2017.167080